A risk score for predicting the incidence of type 2 diabetes in a middle-aged Korean cohort - The Korean Genome and epidemiology study -

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 1904-1910

  Lim, Nam Kyoo ^a   Park, Sung Hee ^a   Choi, Sun Ja ^a   Lee, Kwang Soo ^a   Park, Hyun Young ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Diabetes; Glycated hemoglobin; Korean; Risk score

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; INCIDENCE; KOREA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROSPECTIVE STUDY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK; SCORING SYSTEM; STATISTICAL MODEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 84864387910     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1236     Document Type: Article

References (32)

1. Tamita K, Katayama M, Takagi T, Akasaka T, Yamamuro A, Kaji S, et al. Impact of newly diagnosed abnormal glucose tolerance on longterm prognosis in patients with acute myocardial infarction. Circ J 2007; 71: 834-841.
2. Kosuge M, Kimura K, Kojima S, Sakamoto T, Matsui K, Ishihara M, et al. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 2005; 69: 375-379.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
4. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011; 35: 303-308.
5. Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes--a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 2000; 50(Suppl 2): S77-S84.
6. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
7. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 2009; 53: 298-304.
8. Al Lawati JA, Tuomilehto J. Diabetes risk score in Oman: A tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract 2007; 77: 438-444.
9. Karvonen M, Pitkaniemi M, Pitkaniemi J, Kohtamaki K, Tajima N, Tuomilehto J. Sex difference in the incidence of insulin-dependent diabetes mellitus: An analysis of the recent epidemiological data: World Health Organization DIAMOND Project Group. Diabetes Metab Rev 1997; 13: 275-291.
10. Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, ErikssonJG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: A tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005; 2: 67-72.
11. Ko G, So W, Tong P, Ma R, Kong A, Ozaki R, et al. A simple risk score to identify Southern Chinese at high risk for diabetes. Diabet Med 2010; 27: 644-649.
12. Lindstrom J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.
13. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Mohlig M, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007; 30: 510-515.
14. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28: 2013-2018.
15. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006; 29: 1872-1877.
16. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? Ann Intern Med 2002; 136: 575-581.
17. Shin C, Abbott RD, Lee H, Kim J, Kimm K. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: The Korean Health and Genome Study. J Hum Hypertens 2004; 18: 717-723.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl 1): S5-S10.
19. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
20. Kennedy KF, Pencina MJ. A SAS macro to compute added predictive ability of new markers predicting a dichotomous outcome. SESUG 2010: Savannah, Georgia; Proceeding of SouthEast SAS User Groups, 2010.
21. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 2004; 23: 1631-1660.
22. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Champman & Hall, 1993.
23. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study. Arch Intern Med 2007; 167: 1068-1074.
24. Chien K, Cai T, Hsu H, Su T, Chang W, Chen M, et al. A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 2009; 52: 443-450.
25. Bozorgmanesh M, Hadaegh F, Ghaffari S, Harati H, Azizi F. A simple risk score effectively predicted type 2 diabetes in Iranian adult population: Population-based cohort study. Eur J Public Health 2011; 21: 554-559.
26. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998; 35: 62-67.
27. Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, et al. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in highrisk subjects. Diabetes Care 1998; 21: 1221-1225.
28. Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G, et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care 2009; 32: 644-646.
29. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, et al. Use of HbA1c in predicting progression to diabetes in French men and women: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619-1625.
30. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004; 19: 1175-1180.
31. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928-935.
32. Lindstrom J, Absetz P, Hemio K, Peltomaki P, Peltonen M. Reducing the risk of type 2 diabetes with nutrition and physical activity - efficacy and implementation of lifestyle interventions in Finland. Public Health Nutr 2010; 13: 993-999.